Buscas alternativas:
decrease units » decrease its (Expandir a busca), release units (Expandir a busca), decrease with (Expandir a busca)
decrease pro » decrease or (Expandir a busca), decrease food (Expandir a busca), decrease treg (Expandir a busca)
pro decrease » to decrease (Expandir a busca), or decrease (Expandir a busca), price decrease (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease any » decrease and (Expandir a busca), decreases and (Expandir a busca), decreased and (Expandir a busca)
any decrease » and decrease (Expandir a busca), can decrease (Expandir a busca), may decrease (Expandir a busca)
units after » unit after (Expandir a busca), habits after (Expandir a busca), fruits after (Expandir a busca)
decrease units » decrease its (Expandir a busca), release units (Expandir a busca), decrease with (Expandir a busca)
decrease pro » decrease or (Expandir a busca), decrease food (Expandir a busca), decrease treg (Expandir a busca)
pro decrease » to decrease (Expandir a busca), or decrease (Expandir a busca), price decrease (Expandir a busca)
decrease not » decrease of (Expandir a busca), decrease akt (Expandir a busca), decrease at (Expandir a busca)
not decrease » to decrease (Expandir a busca), not increase (Expandir a busca), and decrease (Expandir a busca)
decrease any » decrease and (Expandir a busca), decreases and (Expandir a busca), decreased and (Expandir a busca)
any decrease » and decrease (Expandir a busca), can decrease (Expandir a busca), may decrease (Expandir a busca)
units after » unit after (Expandir a busca), habits after (Expandir a busca), fruits after (Expandir a busca)
1
“... de mediadores anti-inflamatórios como a IL-10 e CCL2 e decréscimo de mediadores pró-inflamatórios como TNF...”
Acessar documento
Acessar documento
2
“... de fibrinogénio ser um pró-coagulante, ele é administrado a doentes com coagulopatias e com outros fatores...”
Acessar documento
Acessar documento